Risankizumab 00074-9010-01
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- November 17, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 360 mg/2.4mL |
Selected Package
00074-9010-01Selected2.4 mL in 1 CARTRIDGE (0074-9010-01)